Dr Katharine Stott
Publications for Katharine Stott
Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
2018
Stott KE, Beardsley J, Whalley S, Kibengo FM, Mai NTH, Kolamunnage-Dona R, Hope W, Day J.
Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system
2018
Stott KE, Hope W.
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis
2018
Stott KE, Beardsley J, Kolamunnage-Dona R, Castelazo AS, Kibengo FM, Mai NTH, Day J, Hope W.
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis
2018
K E Stott H Pertinez M G G Sturkenboom M J Boeree R Aarnoutse G Ramachandran A Requena-Méndez C Peloquin C F N Koegelenberg J W C Alffenaar R Ruslami A Tostmann S Swaminathan H McIlleron G Davies
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations
2017
Stott KE, Hope WW
Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort.
2016
Lewis JM, Stott KE, Monnery D, Seden K, Beeching NJ, Chaponda M, Khoo S, Beadsworth MB.
Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.
2016
Vandormael AM, Boulware DR, Tanser FC, Bärnighausen TW, Stott KE, de Oliveira T.
Adequacy of Rifampin Absorption after Jejunostomy Tube Administration.
2016
Stott KE, Singh B, Beadsworth MB, Vaudrey K, Khoo SH, Davies G.
Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa.
2016
Keeley AJ, Beeching NJ, Stott KE, Roberts P, Watson AJ, Beadsworth MB.